PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-99.80%
Negative 10Y revenue/share CAGR while 1113.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-99.53%
Negative 5Y CAGR while 1113.HK stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-99.81%
Negative 3Y CAGR while 1113.HK stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-66.81%
Negative 10Y OCF/share CAGR while 1113.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-55.38%
Negative 5Y OCF/share CAGR while 1113.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-67.26%
Negative 3Y OCF/share CAGR while 1113.HK stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-102.49%
Negative 10Y net income/share CAGR while 1113.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-110.19%
Negative 5Y net income/share CAGR while 1113.HK is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-103.42%
Negative 3Y CAGR while 1113.HK is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5546.99%
Dividend/share CAGR of 5546.99% while 1113.HK is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
12036.01%
Dividend/share CAGR of 12036.01% while 1113.HK is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
1144.67%
3Y dividend/share CAGR of 1144.67% while 1113.HK is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
-38.13%
Inventory is declining while 1113.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.